These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 489982)

  • 1. Macrophages/monocytes require cell-to-cell contact in order to regulate the growth of a murine lymphoma cell line.
    Hewlett G; Opitz HG; Flad HD; Schlumberger HD
    J Immunol; 1979 Nov; 123(5):2265-9. PubMed ID: 489982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth regulation of a murine lymphoma cell line by a 2-mercaptoethanol or macrophage-activated serum factor.
    Hewlett G; Opitz HG; Schlumberger HD; Lemke H
    Eur J Immunol; 1977 Nov; 7(11):781-5. PubMed ID: 304005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
    Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
    J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitro.
    Boyle MD; Ormerod MG
    J Reticuloendothel Soc; 1975 Feb; 17(2):73-83. PubMed ID: 804549
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization and functional properties of tumor cell lines in accessory cell replacement assays.
    Walker EB; Lanier LL; Warner NL
    J Immunol; 1982 Feb; 128(2):852-9. PubMed ID: 7033383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified human macrophage secretions suppress tumor growth in the mouse.
    Cameron DJ
    J Reticuloendothel Soc; 1983 Jul; 34(1):45-52. PubMed ID: 6410064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of murine lymphoma cells by allogeneic immune peritoneal macrophages in vitro: an ultrastructure study.
    Dingemans KP; Pels E; Den Otter W
    J Natl Cancer Inst; 1981 Jan; 66(1):67-79. PubMed ID: 6935467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
    Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
    J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Support versus inhibition of hematopoiesis by two characterized stromal cell types.
    Sitnicka E; Wang QR; Tsai S; Wolf NS
    Stem Cells; 1995 Nov; 13(6):655-65. PubMed ID: 8590867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadjuvant effects of Blastomyces dermatitidis against EL 4 lymphoma in C57BL/6J mice.
    McDaniel LS; Cozad GC
    J Natl Cancer Inst; 1982 Dec; 69(6):1337-42. PubMed ID: 6958909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytes/macrophages infected with Toxoplasma gondii do not increase co-stimulatory molecules while maintaining their migratory ability.
    Seipel D; Ribeiro-Gomes FL; Barcelos MW; Ramalho AV; Kanashiro MM; Kipnis TL; Arnholdt AC
    APMIS; 2009 Sep; 117(9):672-80. PubMed ID: 19703127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
    Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
    Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of tumor binding by the IC-21 macrophage cell line.
    Crawford EK; Latham PS; Shah EM; Hasday JD
    Cancer Res; 1990 Aug; 50(15):4578-83. PubMed ID: 2164442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.